GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,236,000 | +12.0% | 32,834 | -47.5% | 0.01% | +8.3% |
Q2 2022 | $1,997,000 | +429.7% | 62,489 | +473.8% | 0.01% | +300.0% |
Q1 2022 | $377,000 | -65.9% | 10,891 | -71.2% | 0.00% | -72.7% |
Q4 2021 | $1,106,000 | -75.6% | 37,790 | -78.7% | 0.01% | -80.7% |
Q3 2021 | $4,530,000 | +52.4% | 177,799 | +109.4% | 0.06% | +67.6% |
Q2 2021 | $2,973,000 | -6.0% | 84,903 | +9.4% | 0.03% | -15.0% |
Q1 2021 | $3,164,000 | +34.0% | 77,634 | +42.3% | 0.04% | +25.0% |
Q4 2020 | $2,362,000 | +29.1% | 54,539 | +64.3% | 0.03% | +18.5% |
Q3 2020 | $1,830,000 | -43.7% | 33,192 | -35.5% | 0.03% | -51.8% |
Q2 2020 | $3,250,000 | +242.5% | 51,487 | +177.1% | 0.06% | +115.4% |
Q1 2020 | $949,000 | -48.6% | 18,581 | -20.1% | 0.03% | -23.5% |
Q4 2019 | $1,848,000 | +190.6% | 23,249 | +77.4% | 0.03% | +161.5% |
Q3 2019 | $636,000 | -30.3% | 13,105 | -24.5% | 0.01% | -23.5% |
Q2 2019 | $913,000 | +155.0% | 17,362 | +84.5% | 0.02% | -15.0% |
Q3 2018 | $358,000 | -2.2% | 9,410 | +16.1% | 0.02% | +11.1% |
Q2 2018 | $366,000 | +1162.1% | 8,102 | +1005.3% | 0.02% | +800.0% |
Q4 2017 | $29,000 | -85.6% | 733 | -88.8% | 0.00% | -81.8% |
Q3 2017 | $202,000 | -9.8% | 6,519 | -20.5% | 0.01% | -21.4% |
Q2 2017 | $224,000 | +44.5% | 8,205 | +94.7% | 0.01% | +27.3% |
Q1 2017 | $155,000 | +72.2% | 4,214 | -25.6% | 0.01% | +120.0% |
Q1 2016 | $90,000 | – | 5,665 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |